MODULAR MEDICAL INC

Modular Medical insider buys hint at confidence amid FDA hopes for its Pivot™ patch pump—investors weigh dilution risk, revenue trends, and payer strategies.

Insider purchase shows confidence in Modular Medical’s pivot to commercializing its tubeless insulin pump—small trade, big signal for investors.

Frank Morgan’s March 31, 2026 option exercise reveals insider confidence in Modular Medical, buying 500 shares at $4.55 each well below market price.